David Wayne Morrow from Haltom City, TX, age 61

Professional Records

Medicine Doctors

David A. Morrow

View page

Specialties:

Cardiovascular Disease

Work:

Brigham & Womens Clinic Cardiology
75 Francis St Shapiro Bldg, Boston, MA 02115
(857) 307-4000 (phone), (857) 307-1222 (fax)

Education:

Medical School
Harvard Medical School
Graduated: 1994

Procedures:

Cardioversion
Electrocardiogram (EKG or ECG)

Conditions:

Acute Myocardial Infarction (AMI)
Aortic Valvular Disease
Atrial Fibrillation and Atrial Flutter
Cardiac Arrhythmia
Cardiomyopathy

Languages:

English
Spanish

Description:

Dr. Morrow graduated from the Harvard Medical School in 1994. He works in Boston, MA and specializes in Cardiovascular Disease. Dr. Morrow is affiliated with Brigham & Womens Hospital.

David L. Morrow

View page

Specialties:

Family Medicine

Work:

Facey Medical Group
27924 Seco Cyn Rd STE 101, Santa Clarita, CA 91350
(661) 513-2100 (phone), (661) 513-2105 (fax)

Education:

Medical School
Saint Louis University School of Medicine
Graduated: 1992

Conditions:

Abnormal Vaginal Bleeding
Acne
Acute Conjunctivitis
Acute Sinusitis
Allergic Rhinitis

Languages:

English
Spanish

Description:

Dr. Morrow graduated from the Saint Louis University School of Medicine in 1992. He works in Santa Clarita, CA and specializes in Family Medicine. Dr. Morrow is affiliated with Henry Mayo Newhall Hospital and Providence Holy Cross Medical Center.

David J. Morrow

View page

Specialties:

General Surgery

Work:

Bassett Physician GroupBassett Medical Center General Surgery
1 Atwell Rd, Cooperstown, NY 13326
(607) 547-3373 (phone), (607) 547-6553 (fax)

Education:

Medical School
University of Vermont COM
Graduated: 2011

Languages:

English

Description:

Dr. Morrow graduated from the University of Vermont COM in 2011. He works in Cooperstown, NY and specializes in General Surgery. Dr. Morrow is affiliated with Bassett Medical Center.

David M. Morrow

View page

Specialties:

Cosmetic Surgery, Dermatology

Work:

Morrow Institute
69780 Stellar Dr, Rancho Mirage, CA 92270
(760) 202-2770 (phone), (760) 202-4676 (fax)

Education:

Medical School
University of Tennessee College of Medicine at Memphis
Graduated: 1970

Languages:

English
Spanish

Description:

Dr. Morrow graduated from the University of Tennessee College of Medicine at Memphis in 1970. He works in Rancho Mirage, CA and specializes in Cosmetic Surgery and Dermatology. Dr. Morrow is affiliated with Eisenhower Medical Center.

David Morrow

View page

Specialties:

Family Medicine

Work:

Umpqua Community Health Center
150 NE Kenneth Frd Dr, Roseburg, OR 97470
(541) 672-9596 (phone), (541) 672-7146 (fax)

Languages:

English
Spanish

Description:

Mr. Morrow works in Roseburg, OR and specializes in Family Medicine. Mr. Morrow is affiliated with Mercy Medical Center.

David Martin Morrow

View page

Specialties:

Dermatology
Plastic Surgery

Education:

University of Tennessee (1970)
Harbor UCLA Medical Center (1972) *Psychiatry
UCLA Medical Center (1980) *Dermatology

David John Morrow

View page

Lawyers & Attorneys

David Morrow - Lawyer

View page

Office:

Simon, Galasso & Frantz, PLC

Specialties:

Commercial Loans
Secured Transactions
Banking Law
Banking Regulation
Loan Workouts
Trade Finance
Asset Based Finance
Securitization
Bankruptcy
Corporate Law
Real Estate
Partnership Law
Limited Liability Company Law

ISLN:

902348644

Admitted:

1972

University:

Michigan State University, B.A., 1968

Law School:

University of Michigan, J.D., 1972

David Morrow - Lawyer

View page

Office:

Morrow Law Firm

ISLN:

902348637

Admitted:

1962

University:

Mississippi State University, B.S.

Law School:

Mississippi College School of Law, LL.B.

David Morrow - Lawyer

View page

Office:

Morrow Law Firm

Specialties:

General Practice

ISLN:

915582394

Admitted:

1998

University:

United States Air Force Academy, B.S., 1978

Law School:

Mississippi College School of Law, J.D., 1998

License Records

David Frank Morrow

License #:

6431 - Expired

Issued Date:

Jul 30, 1981

Renew Date:

May 31, 2000

Expiration Date:

May 31, 2000

Type:

Certified Public Accountant

Business Records

Name / Title

Company / Classification

Phones & Addresses

Mr. David Morrow
Owner

Morrow's Mt. Vernon Electric
Electric Motor Companies. Electric Motor Manufacturers

214 W 2nd St, Mt Vernon, IN 47620-1809
(812) 838-5641, (812) 838-6921

David Morrow
Partner

David B Morrow CPA P C
Accounting, Auditing, and Bookkeeping Services

4455 Camp Bowie Blvd # 205, Fort Worth, TX 76107

David Morrow
President

Wilshire Enterprises, Inc

David Morrow
Partner

David B Morrow CPA P C
Accounting/Auditing/Bookkeeping

4455 Cp Bowie Blvd, Fort Worth, TX 76107
(817) 738-1118, (817) 738-2962

David Morrow
Director

MNM FOODS, INC
Nonclassifiable Establishments

4455 Cp Bowie Blvd SUITE 205, Fort Worth, TX 76107

David C Morrow
Director

3MORROW ENERGY COMPANY

PO Box 61447, Midland, TX 79711
1601 Elm St, Dallas, TX 75201

David B. Morrow
Treasurer , Director , Vice-President

Jewell Miears Fielder Foundation, Inc

David Morrow
Principal

Mjdr Ventures LLC
Business Services

9117 Windcrest Dr, Dallas, TX 75243

David Morrow
Partner

David B Morrow CPA P C
Accounting, Auditing, and Bookkeeping Services

4455 Camp Bowie Blvd # 205, Fort Worth, TX 76107

News

Bleeding risk clouds Merck's hopes for vorapaxar franchise

View page

Dr. David Morrow of Brigham and Women's Hospital in Boston told the gathering at the American College of Cardiology that 11.2% of the patients taking vorapaxar experienced a cardiovascular event, such as heart attack, stroke or death, compared to 12.4% of the patients in the control arm. Here's the

Date

Mar 26, 2012

Category:

Health

Source:

Google

Merck ponders next step for troubled heart drug

View page

died from heart-related causes versus more than 10 percent of those not given the drug. Moderate or severe bleeding occurred in about 4 percent of those on vorapaxar versus just more than 2 percent of the others, said the studys leader, Dr. David Morrow of Brigham and Womens Hospital in Boston.

Date

Mar 25, 2012

Category:

Health

Source:

Google

WSJ UPDATE: Merck Anticlotting Drug Shows Benefit And Risk -Study

View page

"There is a clear signal of efficacy," said David Morrow, a researcher atHarvard-affiliated Brigham and Women's Hospital, Boston and lead author of thestudy. He added that the increased bleeding risk was "unacceptably high inpatients with a previous stroke." Weighing under about 130 pounds was a

Date

Mar 24, 2012

Source:

Google

Merck ponders next step for troubled heart drug

View page

had died from heart-related causes versus more than 10 percent of those not given the drug. Moderate or severe bleeding occurred in about 4 percent of those on vorapaxar versus just more than 2 percent of the others, said the study's leader, Dr. David Morrow of Brigham and Women's Hospital in Boston.

Date

Mar 24, 2012

Category:

Health

Source:

Google

Merck ponders next step for troubled heart drug

View page

a stroke or had died from heart-related causes versus more than 10 percent of those not given the drug. Moderate or severe bleeding occurred in about 4% of those on vorapaxar versus just more than 2% of the others, said the study's leader, Dr. David Morrow of Brigham and Women's Hospital in Boston.

Date

Mar 24, 2012

Category:

Health

Source:

Google

Merck blood clot drug in limbo after mixed results

View page

"This is the first time we've seen the addition of any new type of anti-platelet drug provide additional long-term protection among stable patients with a history of heart attack," said Dr. David Morrow, a cardiologist from Brigham & Women's Hospital in Boston who led the trial.

Date

Mar 24, 2012

Source:

Google

Merck 'blood thinner' shows mixed results: study

View page

"Of the groups we studied, the benefit was compelling to us only in patients with a prior heart attack," said a statement by lead investigator David Morrow, director of the Samuel A. Levine Cardiac Unit at Brigham & Women's Hospital.

Date

Mar 24, 2012

Source:

Google

ACC: Events Cut, but Bleeding Up with Novel Drug

View page

The rate of cardiovascular death, MI, or stroke was 9.3% with vorapaxar and 10.5% with placebo (HR 0.87, 95% CI 0.80 to 0.94), according to David Morrow, MD, MPH, of Brigham and Women's Hospital in Boston.

Date

Mar 24, 2012

Category:

Modular Tapered Reamer For Bone Preparation And Associated Method

View page

US Patent:

20140276847, Sep 18, 2014

Filed:

May 30, 2014

Appl. No.:

14/291726

Inventors:

- Paynham MA, US
CHARLES WESLEY JAGGERS - DALLAS TX, US
KIMBERLY ANN DWYER - FORT WAYNE IN, US
DAVID WILLIAM MORROW - PLYMOUTH MA, US
BRAD ALAN PARKER - WARSAW IN, US
DANIEL J. BERRY - ROCHESTER MN, US

Assignee:

DEPUY SYNTHES PRODUCTS, LLC - Raynham MA

International Classification:

A61B 17/16

US Classification:

606 80

Abstract:

A kit for use in performing joint arthroplasty is provided. The kit () includes a trial () and a reamer (). The reamer () is for preparing a cavity () in the intramedullary canal () of a long bone () with the use of a driver () and to assist in performing a trial reduction. The reamer () includes a first portion () for placement at least partially in the cavity () of the long bone () and a second portion () operably connected to the first portion (). The reamer () is removably connected to the driver () to rotate the reamer (). The trial () is removably attachable to the reamer ().

Videos & Images